Skip to main content
Category

COVID-19

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice–Based Network

Information on COVID-19 rapidly emerged and expanded at the onset of the pandemic. As of May 2020 it included 17,998 publications. Over 1,500 of those publications addressed rheumatic disease-related topics. The purpose of this review is to identify specific threats to the validity of the COVID-19 literature and to recommend resources for practicing rheumatologists and their patients.

Read More

Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic

Information on COVID-19 rapidly emerged and expanded at the onset of the pandemic. As of May 2020 it included 17,998 publications. Over 1,500 of those publications addressed rheumatic disease-related topics. The purpose of this review is to identify specific threats to the validity of the COVID-19 literature and to recommend resources for practicing rheumatologists and their patients.

Read More

Tracking Clinical Resources for Coronavirus Disease

Information on COVID-19 rapidly emerged and expanded at the onset of the pandemic. As of May 2020 it included 17,998 publications. Over 1,500 of those publications addressed rheumatic disease-related topics. The purpose of this review is to identify specific threats to the validity of the COVID-19 literature and to recommend resources for practicing rheumatologists and their patients.

Read More

Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID-19 Pandemic in Patients With or Without Autoimmune Rheumatic Disease

Impacts from the COVID-19 pandemic were studied in patients with and without autoimmune rheumatic diseases. The authors aimed to compare concerns, social distancing, healthcare disruptions, and telemedicine use in these patients. Concerns about COVID-19 and social distancing behaviors were similar in both groups although patients receiving a biologic or Janus kinase (JAK) inhibitor reported greater concerns and were more likely to avoid leaving the house and engage in social activities. Patients with autoimmune rheumatic diseases were less likely to avoid office visits with similar telemedicine use. Missed office visits were strongly associated with interruptions in immunomodulatory medication.

Read More